Senior Science Editor
at Technology Networks
After obtaining a first-class honors degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
Education
Areas of Expertise
Got a Question for Anna MacDonald?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 335
Industry Insight
Unlocking the Potential of PROTACs in Drug Discovery
To explore how PROTACs are transforming drug discovery, we spoke with Robyn Stoller, business development manager at Cytiva.
Industry Insight
How Is the Cell and Gene Therapy Landscape Evolving?
To explore how the CGT landscape is evolving, Technology Networks spoke with Betty Woo, vice president of Cell, Gene and Advanced Therapies at Thermo Fisher Scientific.
Industry Insight
Driving Customer-Centric Innovation: Agilent’s Organizational Transformation
In this Q&A, Padraig McDonnell discusses how the reorganization aligns with Agilent’s commitment to innovation and customer success, the expected benefits of the new structure and the steps being taken to ensure a seamless transition.
Industry Insight
Unlocking the Human Proteome
We spoke with Dr. Michael Gonzales to learn more about the UKB-PPP and its goals, the technical hurdles of large-scale proteomics and how Olink technology is helping to overcome them.
Infographic
Decoding Rare Diseases: How Genomics Is Transforming Diagnosis
This infographic explores how genomic technologies are enabling earlier and more precise diagnoses for patients.
Industry Insight
Breaking New Ground in Single-Cell Lipidomics
Gilberto Barcellos and Dr. Melanie Bailey discuss the growing interest in single-cell lipidomics, the key challenges researchers face and how the SS2000 is helping to overcome these hurdles.
Industry Insight
How Biopharma Labs Can Tackle GMP Challenges
Mary Kay Bates, senior global cell culture scientist at Thermo Fisher Scientific, explores best practices for implementing GMP regulations in the lab.
Industry Insight
How SPRQ Chemistry Is Breaking Barriers in DNA Sequencing
Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.
Industry Insight
Collaboration Aims To Advance E2-Based Targeted Protein Degradation
Vivek Vishnudas discusses the unique advantages of E2-based TPD and its potential to revolutionize treatment for challenging diseases.
Industry Insight
Revolutionizing Protein Research: Insights Into MolBoolean™ With Professor Ola Söderberg
In this interview, Professor Ola Söderberg explores the development of MolBoolean, its innovative methodology and the advantages it offers over existing techniques.
Advertisement
